Table 1. Clinicopathological characteristics of patients with gastric carcinoma.
Clinicopathological characteristics | Number of cases (n = 95) | |
---|---|---|
Number of cases | % | |
Age (years) | ||
< 60 | 39 | 41.1 |
≥ 60 | 56 | 58.9 |
Gender | ||
Male | 70 | 73.7 |
Female | 25 | 26.3 |
Smoking or drinking | ||
No | 46 | 48.4 |
Yes | 49 | 51.6 |
Histologic grade | ||
Well differentiated | 8 | 8.4 |
Moderately differentiated | 47 | 49.5 |
Poorly differentiated | 40 | 42.1 |
TNM stage | ||
T1 | 20 | 21.6 |
T2 | 20 | 21.6 |
T3 | 21 | 22.1 |
T4 | 34 | 35.7 |
Lymphatic permeation | ||
Absent | 34 | 35.8 |
Present | 61 | 64.2 |
Tumor shape | ||
Ulcerative type | 73 | 76.8 |
Papillary type | 1 | 1.1 |
Superficial type | 11 | 11.6 |
Protrude type | 5 | 5.3 |
Massive type | 2 | 2.1 |
Infiltrative type | 3 | 3.2 |
Histologic type | ||
Adenocarcinoma | 86 | 90.5 |
Signet-ring cell carcinoma | 9 | 9.5 |
Distant metastasis | ||
No | 68 | 71.6 |
Yes | 27 | 28.4 |
EGFR expression | ||
Low | 73 | 78.5 |
High | 20 | 21.5 |
BRD4 expression | ||
Low | 50 | 52.6 |
High | 45 | 47.4 |
Vital status (at the end of follow-up) | ||
Alive | 39 | 41.1 |
Dead | 56 | 58.9 |